SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (2735)11/20/1997 10:38:00 PM
From: mc  Read Replies (1) of 23519
 
BigKNY3, a few questions for you:

1. Do you feel that Viagra will have a high enough failure rate to leave a substantial portion of the market to MUSE and other treatments?

2. If the answer to 1 is yes, then will that portion be at least as big as it is now?

3. And last, there are many different rumors about the target study group in the Viagra trials. Initially it was thought that they were all impotent due to non-physical reasons. Now it seems the more recent comments coming out are that the group was mixed and that Viagra was effective on organically impotent men as well. Which of these do you believe to be true?

I know that without all the results that you are only speculating, but, you seem to have as good a grasp as anyone and I would appreciate your speculations regarding these topics.

Thanks, Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext